| Pharmaceutical Information |
| Drug Name |
Rimantadine hydrochloride |
| Drug ID |
BADD_D01945 |
| Description |
An RNA synthesis inhibitor that is used as an antiviral agent in the prophylaxis and treatment of influenza. |
| Indications and Usage |
For the prophylaxis and treatment of illness caused by various strains of influenza A virus in adults. |
| Marketing Status |
approved; investigational |
| ATC Code |
J05AC02 |
| DrugBank ID |
DB00478
|
| KEGG ID |
D00901
|
| MeSH ID |
D012299
|
| PubChem ID |
15165
|
| TTD Drug ID |
D0P2NN
|
| NDC Product Code |
63818-0434; 0115-1911 |
| UNII |
JEI07OOS8Y
|
| Synonyms |
Rimantadine | Remantadine | Riamantadine | Roflual | Flumadine | Rimantadine Hydrochloride | Hydrochloride, Rimantadine |
|
| Chemical Information |
| Molecular Formula |
C12H22ClN |
| CAS Registry Number |
1501-84-4 |
| SMILES |
CC(C12CC3CC(C1)CC(C3)C2)N.Cl |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
|
|
|
